Evidence map›Paper›PMID 19567868›Full record

ArticleThe Journal of biological chemistry2009

T-type Ca2+ channels promote oxygenation-induced closure of the rat ductus arteriosus not only by vasoconstriction but also by neointima formation.

Toru Akaike, Mei-Hua Jin, Utako Yokoyama, Hiroko Izumi-Nakaseko, Qibin Jiao, Shiho Iwasaki, Mari Iwamoto, Shigeru Nishimaki, Motohiko Sato, Shumpei Yokota and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Transcriptional regulation of α1H T-type calcium channel under hypoxia.American journal of physiology. Cell physiology · 2014
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Current Perspectives on Pathobiology of the Ductus Arteriosus.Journal of clinical & experimental cardiology · 2012
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Toru AkaikeCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Mei-Hua Jin
Utako Yokoyama
Hiroko Izumi-Nakaseko
Qibin Jiao
Shiho Iwasaki
Mari Iwamoto
Shigeru Nishimaki
Motohiko Sato
Shumpei Yokota
Yoshinori Kamiya
Satomi Adachi-Akahane
Yoshihiro Ishikawa
Susumu Minamisawa
Waseda University · JPYokohama City University · JPCardiovascular Institute Hospital · JPToho University · JP

Funding

Catalytic activation of adenylyl cyclase type VR01GM067773 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ISHIKAWA, YOSHIHIRO · 2004 to 2007
$1.3M
NIGMS NIH HHS R01 GM067773
6 · The paper itself

Abstract

The ductus arteriosus (DA), an essential vascular shunt for fetal circulation, begins to close immediately after birth. Although Ca(2+) influx through several membrane Ca(2+) channels is known to regulate vasoconstriction of the DA, the role of the T-type voltage-dependent Ca(2+) channel (VDCC) in DA closure remains unclear. Here we found that the expression of alpha1G, a T-type isoform that is known to exhibit a tissue-restricted expression pattern in the rat neonatal DA, was significantly up-regulated in oxygenated rat DA tissues and smooth muscle cells (SMCs). Immunohistological analysis revealed that alpha1G was localized predominantly in the central core of neonatal DA at birth. DA SMC migration was significantly increased by alpha1G overexpression. Moreover, it was decreased by adding alpha1G-specific small interfering RNAs or using R(-)-efonidipine, a highly selective T-type VDCC blocker. Furthermore, an oxygenation-mediated increase in an intracellular Ca(2+) concentration of DA SMCs was significantly decreased by adding alpha1G-specific siRNAs or using R(-)-efonidipine. Although a prostaglandin E receptor EP4 agonist potently promoted intimal thickening of the DA explants, R(-)-efonidipine (10(-6) m) significantly inhibited EP4-promoted intimal thickening by 40% using DA tissues at preterm in organ culture. Moreover, R(-)-efonidipine (10(-6) m) significantly attenuated oxygenation-induced vasoconstriction by approximately 27% using a vascular ring of fetal DA at term. Finally, R(-)-efonidipine significantly delayed the closure of in vivo DA in neonatal rats. These results indicate that T-type VDCC, especially alpha1G, which is predominantly expressed in neonatal DA, plays a unique role in DA closure, implying that T-type VDCC is an alternative therapeutic target to regulate the patency of DA.

Indexed as

AnimalsAnimals, NewbornCalciumCalcium Channel BlockersCalcium Channels, T-TypeDihydropyridinesDuctus ArteriosusMuscle, Smooth, VascularNitrophenolsOrgan Culture TechniquesOrganophosphorus CompoundsProtein IsoformsRatsRats, WistarReceptors, Prostaglandin EReceptors, Prostaglandin E, EP4 SubtypeCalciumCalcium Channel BlockersCalcium Channels, T-TypeDihydropyridinesefonidipineNitrophenolsOrganophosphorus CompoundsProtein IsoformsPtger4 protein, ratReceptors, Prostaglandin EReceptors, Prostaglandin E, EP4 Subtype

Identifiers

PMID19567868
PMCPMC2781997
OpenAlexW1964304264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.